Anaptysbio, Inc (ANAB): EPS (Diluted)
-$0.46
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.46 | n/m | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | -$5.12 | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$6.08 | n/m | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | -$4.57 | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$2.11 | n/m | 2024-03-11, From 2021-01-01 |
| 2020-12-31 | -$0.73 | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$3.60 | n/m | 2022-03-07, From 2019-01-01 |
| 2018-12-31 | -$2.50 | n/m | 2020-03-02, From 2018-01-01 |
| 2017-12-31 | -$1.52 | n/m | 2019-02-28, From 2017-01-01 |
| 2016-12-31 | -$1.62 | n/a | 2018-03-05, From 2016-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Anaptysbio, Inc (ANAB) | 2025-12-31 | -$0.46 | n/m |
| Akebia Therapeutics, Inc. (AKBA) | 2025-12-31 | -$0.02 | n/m |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $0.61 | -1.6% |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $2.30 | n/m |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | -$3.29 | n/m |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | -$1.28 | n/m |
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | -$3.74 | n/m |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | -$1.41 | n/m |
| Amarin Corp PLC (AMRN) | 2025-12-31 | -$0.09 | n/m |
Compare ANAB, AKBA, PBYI, KROS side by side · Screen every company in Pharmaceutical Preparations ↗